Transcription factor AP-2α triggers apoptosis in cardiac myocytes

被引:0
|
作者
F U Müller
K Loser
U Kleideiter
J Neumann
C von Wallbrunn
T Dobner
H-H Scheld
H Bantel
I H Engels
K Schulze-Osthoff
W Schmitz
机构
[1] Institute of Pharmacology and Toxicology,Department of Thoracic and Cardiovascular Surgery
[2] University of Münster,undefined
[3] Domagkstr. 12,undefined
[4] Institute of Medical Microbiology and Hygiene,undefined
[5] University of Regensburg,undefined
[6] Franz-Josef-Strauss-Allee 11,undefined
[7] University of Münster,undefined
[8] Albert-Schweitzer-Str. 33,undefined
[9] Institute of Molecular Medicine,undefined
[10] University of Düsseldorf,undefined
[11] Universitätsstr. 1,undefined
来源
关键词
activator protein 2 alpha; apoptosis; human heart failure; transcription factor; rat cardiomyocytes;
D O I
暂无
中图分类号
学科分类号
摘要
Idiopathic-dilated cardiomyopathy (IDC) is a common primary myocardial disease of unknown etiology associated with apoptosis, cardiac dilatation, progressive heart failure and increased mortality. An elevation of the transcription factor activator protein 2α (AP-2α) is involved in vertebrate embryonic development and oncogenesis. Here, we show that AP-2α protein is expressed in the human heart and increased in human failing myocardium with IDC. Adenovirus-mediated overexpression of human AP-2α triggered apoptosis and increased mRNA levels of Bcl-2 family members Bax and Bcl-x in rat cardiomyocytes. Immunohistological analysis of human myocardium revealed an increased percentage of AP-2α-positive nuclei in IDC and, interestingly, a colocalization of AP-2α-positive but not -negative cells with a caspase-cleaved fragment of poly(ADP-ribose)polymerase. We suggest AP-2α as a novel cardiac regulator implicated in the activation of apoptosis in IDC.
引用
收藏
页码:485 / 493
页数:8
相关论文
共 50 条
  • [41] THE TRANSCRIPTION FACTOR AP-2 REGULATES TRANSCRIPTION OF U6 SNRNA GENES
    STROM, AC
    WESTIN, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 174 - 174
  • [42] Role of AP-2 transcription factor in morphogenesis of stratified epithelium.
    WestMays, JA
    Sadow, PM
    Daryanani, HA
    Zieske, JD
    Fini, ME
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 174 - 174
  • [43] SPECIFIC PROTEIN-PROTEIN INTERACTIONS OF TRANSCRIPTION FACTOR AP-2
    IMHOF, A
    MOSER, M
    PSCHERER, A
    TAINSKY, MA
    BUTTNER, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 46 - 46
  • [44] Transcription factor AP-2 and monoaminergic functions in the central nervous system
    Damberg, Mattias
    Nilsson, Kent
    Sjoberg, Rickard
    Oreland, Lars
    Leppert, Jerzy
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 701 - 701
  • [45] Transcription factor AP-2 controls transcription of the human transforming growth factor-alpha gene
    Wang, DY
    Shin, TH
    Kudlow, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) : 14244 - 14250
  • [46] The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers
    Kolat, Damian
    Kaluzinska, Zaneta
    Bednarek, Andrzej K.
    Pluciennik, Elzbieta
    BIOSCIENCE REPORTS, 2019, 39
  • [47] The role of the AP-2α transcription factor in ventral body wall closure.
    Brewer, SL
    Donaldson, S
    Williams, T
    DEVELOPMENTAL BIOLOGY, 2001, 235 (01) : 191 - 191
  • [48] Deletion of transcription factor AP-2α gene attenuates fibroblast differentiation into myofibroblast
    Ross, Gracious R.
    Edwards, Stacie
    Warner, Catherine
    Homar, Peter
    Downey, Francis X.
    Emelyanova, Larisa
    Rizyi, Farhan
    Jahangir, Arshad
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (09) : 6494 - 6498
  • [49] Cellular requirements for AP-2α transcription factor during early lens development
    West-Mays, JA
    Papagiotas, SS
    Nottoli, T
    Auman, H
    Williams, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S757 - S757
  • [50] Expression of transcription factor AP-2α predicts survival in epithelial ovarian cancer
    Anttila, MA
    Kellokoski, JK
    Moisio, KI
    Mitchell, PJ
    Saarikoski, S
    Syrjänen, K
    Kosma, VM
    BRITISH JOURNAL OF CANCER, 2000, 82 (12) : 1974 - 1983